company background image
4547 logo

Kissei Pharmaceutical TSE:4547 Stock Report

Last Price

JP¥3.10k

Market Cap

JP¥139.2b

7D

-2.1%

1Y

5.5%

Updated

13 Jun, 2024

Data

Company Financials +

Kissei Pharmaceutical Co., Ltd.

TSE:4547 Stock Report

Market Cap: JP¥139.2b

Kissei Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kissei Pharmaceutical
Historical stock prices
Current Share PriceJP¥3,100.00
52 Week HighJP¥3,720.00
52 Week LowJP¥2,866.00
Beta0.062
1 Month Change-1.59%
3 Month Change-14.48%
1 Year Change5.51%
3 Year Change41.55%
5 Year Change15.63%
Change since IPO46.84%

Recent News & Updates

Kissei Pharmaceutical's (TSE:4547) Shareholders May Want To Dig Deeper Than Statutory Profit

May 21
Kissei Pharmaceutical's (TSE:4547) Shareholders May Want To Dig Deeper Than Statutory Profit

Kissei Pharmaceutical Co., Ltd. (TSE:4547) Yearly Results: Here's What Analysts Are Forecasting For This Year

May 09
Kissei Pharmaceutical Co., Ltd. (TSE:4547) Yearly Results: Here's What Analysts Are Forecasting For This Year

Kissei Pharmaceutical (TSE:4547) Is Due To Pay A Dividend Of ¥41.00

Mar 27
Kissei Pharmaceutical (TSE:4547) Is Due To Pay A Dividend Of ¥41.00

Recent updates

Kissei Pharmaceutical's (TSE:4547) Shareholders May Want To Dig Deeper Than Statutory Profit

May 21
Kissei Pharmaceutical's (TSE:4547) Shareholders May Want To Dig Deeper Than Statutory Profit

Kissei Pharmaceutical Co., Ltd. (TSE:4547) Yearly Results: Here's What Analysts Are Forecasting For This Year

May 09
Kissei Pharmaceutical Co., Ltd. (TSE:4547) Yearly Results: Here's What Analysts Are Forecasting For This Year

Kissei Pharmaceutical (TSE:4547) Is Due To Pay A Dividend Of ¥41.00

Mar 27
Kissei Pharmaceutical (TSE:4547) Is Due To Pay A Dividend Of ¥41.00

Kissei Pharmaceutical (TSE:4547) Is Due To Pay A Dividend Of ¥41.00

Mar 13
Kissei Pharmaceutical (TSE:4547) Is Due To Pay A Dividend Of ¥41.00

Kissei Pharmaceutical (TSE:4547) Has Announced A Dividend Of ¥41.00

Feb 27
Kissei Pharmaceutical (TSE:4547) Has Announced A Dividend Of ¥41.00

Shareholder Returns

4547JP PharmaceuticalsJP Market
7D-2.1%-0.7%0.3%
1Y5.5%-0.7%17.5%

Return vs Industry: 4547 exceeded the JP Pharmaceuticals industry which returned -0.7% over the past year.

Return vs Market: 4547 underperformed the JP Market which returned 17.5% over the past year.

Price Volatility

Is 4547's price volatile compared to industry and market?
4547 volatility
4547 Average Weekly Movement4.7%
Pharmaceuticals Industry Average Movement3.7%
Market Average Movement3.9%
10% most volatile stocks in JP Market7.5%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4547 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4547's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19461,359Mutsuo Kanzawawww.kissei.co.jp

Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia. Its products in pipeline include CG0070, which is in Phase III clinical trial to treat non-muscle-invasive bladder cancer; Linzagolix, which is in Phase III clinical trial for the treatment of uterine fibroids and endometriosis; KDT-3594, which is in Phase II clinical trial to treat Parkinson's disease; KSP-0243 that is in Phase II clinical trial to treat Ulcerative colitis; and Difelikefalin, which is in Phase III clinical trial to treat uremic pruritus in dialysis patients.

Kissei Pharmaceutical Co., Ltd. Fundamentals Summary

How do Kissei Pharmaceutical's earnings and revenue compare to its market cap?
4547 fundamental statistics
Market capJP¥139.25b
Earnings (TTM)JP¥11.16b
Revenue (TTM)JP¥75.58b

12.3x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4547 income statement (TTM)
RevenueJP¥75.58b
Cost of RevenueJP¥38.24b
Gross ProfitJP¥37.34b
Other ExpensesJP¥26.18b
EarningsJP¥11.16b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)252.46
Gross Margin49.41%
Net Profit Margin14.77%
Debt/Equity Ratio0.6%

How did 4547 perform over the long term?

See historical performance and comparison

Dividends

2.9%

Current Dividend Yield

33%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.